US Bancorp’s NuVasive, Inc. NUVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-612
| Closed | -$25.5K | – | 4161 |
|
|
2023
Q2 | $25.5K | Sell |
612
-106
| -15% | -$4.35K | ﹤0.01% | 2860 |
|
|
2023
Q1 | $29.7K | Sell |
718
-503
| -41% | -$21.5K | ﹤0.01% | 2782 |
|
|
2022
Q4 | $50.4K | Sell |
1,221
-47
| -4% | -$1.9K | ﹤0.01% | 2523 |
|
|
2022
Q3 | $56K | Sell |
1,268
-1,587
| -56% | -$76.9K | ﹤0.01% | 2468 |
|
|
2022
Q2 | $141K | Sell |
2,855
-1,008
| -26% | -$54.1K | ﹤0.01% | 2045 |
|
|
2022
Q1 | $220K | Sell |
3,863
-332
| -8% | -$17.6K | ﹤0.01% | 1905 |
|
|
2021
Q4 | $220K | Sell |
4,195
-382
| -8% | -$20.8K | ﹤0.01% | 1936 |
|
|
2021
Q3 | $273K | Sell |
4,577
-1,336
| -23% | -$82.4K | ﹤0.01% | 1825 |
|
|
2021
Q2 | $401K | Sell |
5,913
-1,585
| -21% | -$108K | ﹤0.01% | 1660 |
|
|
2021
Q1 | $492K | Buy |
7,498
+683
| +10% | +$41K | ﹤0.01% | 1503 |
|
|
2020
Q4 | $384K | Sell |
6,815
-670
| -9% | -$33K | ﹤0.01% | 1580 |
|
|
2020
Q3 | $363K | Sell |
7,485
-1,376
| -16% | -$74.1K | ﹤0.01% | 1507 |
|
|
2020
Q2 | $494K | Buy |
8,861
+581
| +7% | +$33.6K | ﹤0.01% | 1301 |
|
|
2020
Q1 | $419K | Sell |
8,280
-779
| -9% | -$52.2K | ﹤0.01% | 1296 |
|
|
2019
Q4 | $699K | Sell |
9,059
-762
| -8% | -$53.8K | ﹤0.01% | 1205 |
|
|
2019
Q3 | $623K | Sell |
9,821
-1,974
| -17% | -$123K | ﹤0.01% | 1257 |
|
|
2019
Q2 | $691K | Sell |
11,795
-1,885
| -14% | -$111K | ﹤0.01% | 1242 |
|
|
2019
Q1 | $776K | Sell |
13,680
-1,187
| -8% | -$63.1K | ﹤0.01% | 1185 |
|
|
2018
Q4 | $736K | Buy |
14,867
+6,418
| +76% | +$386K | ﹤0.01% | 1147 |
|
|
2018
Q3 | $601K | Buy |
8,449
+2,693
| +47% | +$171K | ﹤0.01% | 1358 |
|
|
2018
Q2 | $300K | Buy |
5,756
+4,752
| +473% | +$249K | ﹤0.01% | 1669 |
|
|
2018
Q1 | $52K | Sell |
1,004
-253
| -20% | -$12.8K | ﹤0.01% | 2592 |
|
|
2017
Q4 | $73K | Buy |
1,257
+278
| +28% | +$15.8K | ﹤0.01% | 2417 |
|
|
2017
Q3 | $54K | Sell |
979
-757
| -44% | -$50.1K | ﹤0.01% | 2540 |
|
|
2017
Q2 | $134K | Sell |
1,736
-665
| -28% | -$49.7K | ﹤0.01% | 2044 |
|
|
2017
Q1 | $180K | Buy |
2,401
+41
| +2% | +$2.98K | ﹤0.01% | 1871 |
|
|
2016
Q4 | $159K | Buy |
2,360
+537
| +29% | +$34.6K | ﹤0.01% | 1895 |
|
|
2016
Q3 | $122K | Buy |
1,823
+950
| +109% | +$60.5K | ﹤0.01% | 1991 |
|
|
2016
Q2 | $52K | Buy |
873
+756
| +646% | +$40.9K | ﹤0.01% | 2388 |
|
|
2016
Q1 | $6K | Sell |
117
-3,735
| -97% | -$169K | ﹤0.01% | 3140 |
|
|
2015
Q4 | $208K | Sell |
3,852
-1,245
| -24% | -$63.5K | ﹤0.01% | 1687 |
|
|
2015
Q3 | $246K | Buy |
5,097
+5,015
| +6,116% | +$259K | ﹤0.01% | 1635 |
|
|
2015
Q2 | $4K | Hold |
82
| – | – | ﹤0.01% | 3348 |
|
|
2015
Q1 | $4K | Hold |
82
| – | – | ﹤0.01% | 3347 |
|
|
2014
Q4 | $4K | Sell |
82
-368
| -82% | -$15.3K | ﹤0.01% | 3337 |
|
|
2014
Q3 | $16K | Sell |
450
-191
| -30% | -$6.8K | ﹤0.01% | 2927 |
|
|
2014
Q2 | $23K | Hold |
641
| – | – | ﹤0.01% | 2814 |
|
|
2014
Q1 | $25K | Buy |
641
+191
| +42% | +$7.02K | ﹤0.01% | 2761 |
|
|
2013
Q4 | $15K | Sell |
450
-3,857
| -90% | -$116K | ﹤0.01% | 2876 |
|
|
2013
Q3 | $105K | Buy |
4,307
+110
| +3% | +$2.71K | ﹤0.01% | 2009 |
|
|
2013
Q2 | $104K | Buy |
+4,197
| New | +$91.8K | ﹤0.01% | 1993 |
|
Other funds holding NUVA
US Bancorp's NUVA Position: Q3 2023 in Review
US Bancorp sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 612 shares — an estimated $25.5K sold.
US Bancorp first reported a position in NUVA in Q2 2013 and held it in 41 quarters. The position peaked at $776K in Q1 2019. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.
- US Bancorp reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
- US Bancorp sold 612 NuVasive, Inc. shares in Q3 2023, an estimated $25.5K.
- US Bancorp first reported a position in NuVasive, Inc. in Q2 2013 and held it in 41 quarters.
- US Bancorp's NuVasive, Inc. position peaked at $776K in Q1 2019.
- 2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.
Based on US Bancorp's 13F filing for Q3 2023, filed 3 Nov 2023.